Personalized antiplatelet therapy for coronary artery disease patients: is this the future? - Wikidata - wikimedia - TriplyDB

Personalized antiplatelet therapy for coronary artery disease patients: is this the future?

Personalized antiplatelet therapy for coronary artery disease patients: is this the future?

http://www.wikidata.org/entity/Q37642822

about

Dosing strategies for antiplatelet therapy in percutaneous coronary intervention.

P2860

Q37752222-B6B41167-477D-43E1-9D46-5B46D583C481

P2860

Personalized antiplatelet therapy for coronary artery disease patients: is this the future?

http://www.wikidata.org/entity/Q37642822

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Personalized antiplatelet ther ...... patients: is this the future?

@en

Personalized antiplatelet ther ...... patients: is this the future?

@nl

type

label

Personalized antiplatelet ther ...... patients: is this the future?

@en

Personalized antiplatelet ther ...... patients: is this the future?

@nl

prefLabel

Personalized antiplatelet ther ...... patients: is this the future?

@en

Personalized antiplatelet ther ...... patients: is this the future?

@nl

P1433

Q37642822-51C00A89-3C26-4C22-AA83-99B991208E7D

P1476

Q37642822-96904FCA-CEED-45F9-AC50-70A4788D6B24

P2093

Q37642822-0017CAB5-9670-48B4-A855-8C303D469724

Q37642822-3C6A13F8-7D66-4AE0-B927-A324AB93801F

Q37642822-4392C53C-CE8B-4C9C-B10E-4929CE8C1A74

Q37642822-4668F03F-B4BC-43EC-B524-7FC3F0556466

Q37642822-B0523F46-F9E0-41AB-A36A-5CB03BBB7E18

P2860

Q37642822-007A7C73-7998-423E-8FFD-7DFC7BC31286

Q37642822-12722C36-A97D-4684-8251-83DA7C6444D9

Q37642822-1653DA1E-4139-44F4-8521-44922E45BA1E

Q37642822-1DF1D63C-BD93-49AD-A6C2-AA94634E7B30

Q37642822-1F275A14-172C-477B-80A8-EE6DD7922B7C

Q37642822-2917250A-7D2A-4B61-B746-9BD95F19CFF1

Q37642822-2AF6407F-AD31-444C-A93B-ED3BF7A003AA

Q37642822-2CB580C6-C076-41CB-911D-A6CCC7E01BBA

Q37642822-382D96A2-AFAC-440B-BE0D-30B7DDE5B00D

Q37642822-39A2DA3C-39A6-45BE-8185-EB7C3EBBDFAE

P304

Q37642822-201D62DB-4AB1-4278-9FA2-B11551B22DD3

P31

Q37642822-A1122775-B0BF-4953-BBE4-363AA2379498

P356

Q37642822-40DD653B-39FB-437A-8C92-424C2F15CD28

P433

Q37642822-5039B023-ECDC-4591-A4BA-3C923DDDCF78

P478

Q37642822-971F8E99-B98E-4A9D-B427-976C137EE823

P50

Q37642822-BBA39135-02AC-4523-99EB-1753A0BBBBDE

P577

Q37642822-DCEC3718-DCE7-4E13-B9C7-4A5037473057

P698

Q37642822-E21CDFAD-74E5-4267-B6BE-C7F17C11BB90

P356

P1433

Expert Review of Cardiovascular Therapy

P1476

Personalized antiplatelet ther ...... patients: is this the future?

@en

P2093

Axel De Labriolle

http://www.w3.org/2001/XMLSchema#string

Franck Paganelli

http://www.w3.org/2001/XMLSchema#string

Laurence Camoin-Jau

http://www.w3.org/2001/XMLSchema#string

Laurent Bonello

http://www.w3.org/2001/XMLSchema#string

Paul Barragan

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the platelet ADP receptor targeted by antithrombotic drugs

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation

P304

1525-1532

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERC.09.146

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19954314

http://www.w3.org/2001/XMLSchema#string